FEXODIN 180 fexofenadine hydrochloride 180 mg tablet blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

fexofenadine hydrochloride, Quantity: 180 mg

Available from:

Nova Pharmaceuticals Australasia Pty Ltd

INN (International Name):

Fexofenadine hydrochloride

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: povidone; lactose monohydrate; magnesium stearate; maize starch; purified talc; sodium lauryl sulfate; purified water; microcrystalline cellulose; croscarmellose sodium; titanium dioxide; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; lecithin

Administration route:

Oral

Units in package:

40, 50, 60, 70, 80, 90 and 100, 10, 12, 20, 24, 30, 36

Prescription type:

(S2) Pharmacy Medicine

Therapeutic indications:

Relief of symptoms associated with seasonal allergic rhinitis or urticaria for adults and children aged 12 years and over

Product summary:

Visual Identification: Peach coloured, capsule shaped, biconvex, bevelled edged film-coated tablet debossed with ' F ' one side and plain on the other side.; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Authorization status:

Licence status A

Authorization date:

2017-05-16